Some secoiridoids from extra virgin olive oil, i.e., oleuropein aglycone and decarboxymethyl oleuropein aglycone, have been demonstrated to activate AMPK, which results in the inhibition of the mammalian target of rapamycin (mTOR) in breast cancer cells [18,27]. The gene discussed is MTOR; the disease is breast carcinoma.